Detection and quantification of pathogen-derived antigenic structures is a key method for the initial diagnosis and follow-up of various infectious diseases. Complex parasitic diseases such as leishmaniasis require highly sensitive and specific tests prior to treatment with potentially toxic drugs. To investigate the diagnostic potential of cell surface glycans found on Leishmania parasites, we identified diagnostically relevant glycan epitopes and used synthetic glycan microarrays to screen sera from infected humans and dogs. On the basis of the screening results, we selected a tetrasaccharide to generate anti-glycan antibodies. The corresponding tetrasaccharide-carrier protein conjugate was immunogenic in mice, and sera obtained from immunized mice specifically detected the Leishmania parasite. These results demonstrate how synthetic glycan arrays, in combination with immunological methods, help to identify promising carbohydrate antigens for pathogen detection.
NCBI PubMed ID: 24004239Publication DOI: 10.1021/cb400602kJournal NLM ID: 101282906Publisher: Washington, DC: American Chemical Society
Correspondence: peter.seeberger
mpikg.mpg.de; chakkumkal.anish
mpikg.mpg.de
Institutions: Max-Planck Institute of Colloids and Interfaces, 14424 Potsdam, Germany, Mikrobiologisches Institut - Klinische Mikrobiologie, Immunologie und Hygiene, Universitatsklinikum Erlangen, Friedrich-Alexander Universitat Erlangen-Nurnberg, Erlangen, Germany, Laboratory of Clinical Bacteriology Parasitology Zoonoses and Geographical Medicine, Faculty of Medicine, University of Crete, Heraklion, Greece
Methods: chemical synthesis, antibody binding, immunization, conjugation, immunofluorescence analyses, immunogenicity evaluation
Found